nodes	percent_of_prediction	percent_of_DWPC	metapath
Orlistat—CYP3A4—Temozolomide—brain cancer	0.0571	0.486	CbGbCtD
Orlistat—CYP3A4—Lomustine—brain cancer	0.0485	0.414	CbGbCtD
Orlistat—LIPF—pituitary gland—brain cancer	0.0206	0.0804	CbGeAlD
Orlistat—CYP3A4—Etoposide—brain cancer	0.0117	0.0999	CbGbCtD
Orlistat—DAGLA—head—brain cancer	0.0102	0.0396	CbGeAlD
Orlistat—DAGLA—central nervous system—brain cancer	0.00928	0.0362	CbGeAlD
Orlistat—DAGLA—cerebellum—brain cancer	0.00907	0.0354	CbGeAlD
Orlistat—PLA2G7—pituitary gland—brain cancer	0.00832	0.0325	CbGeAlD
Orlistat—PLA2G7—medulla oblongata—brain cancer	0.00803	0.0313	CbGeAlD
Orlistat—ABHD16A—pituitary gland—brain cancer	0.00781	0.0304	CbGeAlD
Orlistat—FASN—telencephalon—brain cancer	0.00754	0.0294	CbGeAlD
Orlistat—ABHD16A—medulla oblongata—brain cancer	0.00754	0.0294	CbGeAlD
Orlistat—DAGLA—brain—brain cancer	0.00737	0.0287	CbGeAlD
Orlistat—PLA2G7—midbrain—brain cancer	0.00734	0.0286	CbGeAlD
Orlistat—ABHD12—pituitary gland—brain cancer	0.00732	0.0285	CbGeAlD
Orlistat—PNLIP—pituitary gland—brain cancer	0.00732	0.0285	CbGeAlD
Orlistat—PLA2G7—spinal cord—brain cancer	0.00716	0.0279	CbGeAlD
Orlistat—ABHD12—medulla oblongata—brain cancer	0.00706	0.0275	CbGeAlD
Orlistat—DAGLB—cerebellum—brain cancer	0.00703	0.0274	CbGeAlD
Orlistat—ABHD16A—midbrain—brain cancer	0.00689	0.0269	CbGeAlD
Orlistat—ABHD16A—spinal cord—brain cancer	0.00672	0.0262	CbGeAlD
Orlistat—ABHD12—midbrain—brain cancer	0.00645	0.0252	CbGeAlD
Orlistat—PLA2G7—endocrine gland—brain cancer	0.00645	0.0251	CbGeAlD
Orlistat—ABHD12—spinal cord—brain cancer	0.0063	0.0246	CbGeAlD
Orlistat—FASN—pituitary gland—brain cancer	0.00614	0.0239	CbGeAlD
Orlistat—FASN—medulla oblongata—brain cancer	0.00593	0.0231	CbGeAlD
Orlistat—DAGLB—brain—brain cancer	0.00571	0.0223	CbGeAlD
Orlistat—PNLIP—endocrine gland—brain cancer	0.00567	0.0221	CbGeAlD
Orlistat—PNLIP—head—brain cancer	0.0056	0.0218	CbGeAlD
Orlistat—FASN—midbrain—brain cancer	0.00542	0.0211	CbGeAlD
Orlistat—ABHD16A—cerebellum—brain cancer	0.00533	0.0208	CbGeAlD
Orlistat—FASN—spinal cord—brain cancer	0.00528	0.0206	CbGeAlD
Orlistat—ABHD12—cerebellum—brain cancer	0.00499	0.0195	CbGeAlD
Orlistat—PLA2G7—brain—brain cancer	0.00461	0.018	CbGeAlD
Orlistat—FASN—cerebellum—brain cancer	0.00419	0.0163	CbGeAlD
Orlistat—ABHD12—brain—brain cancer	0.00406	0.0158	CbGeAlD
Orlistat—FASN—brain—brain cancer	0.0034	0.0133	CbGeAlD
Orlistat—PLA2G4A—pituitary gland—brain cancer	0.00295	0.0115	CbGeAlD
Orlistat—Haemoglobin—Lomustine—brain cancer	0.00291	0.00815	CcSEcCtD
Orlistat—Haemorrhage—Lomustine—brain cancer	0.00289	0.0081	CcSEcCtD
Orlistat—PLA2G4A—medulla oblongata—brain cancer	0.00285	0.0111	CbGeAlD
Orlistat—Nail disorder—Etoposide—brain cancer	0.00273	0.00764	CcSEcCtD
Orlistat—PLA2G4A—midbrain—brain cancer	0.0026	0.0102	CbGeAlD
Orlistat—Neoplasm—Hydroxyurea—brain cancer	0.00256	0.00717	CcSEcCtD
Orlistat—Alopecia—Lomustine—brain cancer	0.00255	0.00716	CcSEcCtD
Orlistat—PLA2G4A—spinal cord—brain cancer	0.00254	0.0099	CbGeAlD
Orlistat—Amenorrhoea—Temozolomide—brain cancer	0.00251	0.00705	CcSEcCtD
Orlistat—Drug interaction—Carmustine—brain cancer	0.00246	0.00691	CcSEcCtD
Orlistat—Infection—Carboplatin—brain cancer	0.00233	0.00654	CcSEcCtD
Orlistat—PLA2G4A—endocrine gland—brain cancer	0.00229	0.00892	CbGeAlD
Orlistat—Hepatic failure—Hydroxyurea—brain cancer	0.00228	0.00641	CcSEcCtD
Orlistat—Pancreatitis—Procarbazine—brain cancer	0.00225	0.0063	CcSEcCtD
Orlistat—Sweating increased—Procarbazine—brain cancer	0.00223	0.00626	CcSEcCtD
Orlistat—Vaginal inflammation—Temozolomide—brain cancer	0.00221	0.00619	CcSEcCtD
Orlistat—Dermatitis bullous—Hydroxyurea—brain cancer	0.00215	0.00602	CcSEcCtD
Orlistat—Vaginal infection—Temozolomide—brain cancer	0.00209	0.00585	CcSEcCtD
Orlistat—Neoplasm—Carmustine—brain cancer	0.00207	0.0058	CcSEcCtD
Orlistat—PLA2G4A—central nervous system—brain cancer	0.00206	0.00804	CbGeAlD
Orlistat—Infection—Lomustine—brain cancer	0.00204	0.00572	CcSEcCtD
Orlistat—Cardiovascular disorder—Etoposide—brain cancer	0.00201	0.00564	CcSEcCtD
Orlistat—Pain—Carboplatin—brain cancer	0.00201	0.00563	CcSEcCtD
Orlistat—Neuropathy peripheral—Procarbazine—brain cancer	0.002	0.00562	CcSEcCtD
Orlistat—Neoplasm—Temozolomide—brain cancer	0.002	0.0056	CcSEcCtD
Orlistat—Diabetes mellitus—Carmustine—brain cancer	0.00191	0.00535	CcSEcCtD
Orlistat—Body temperature increased—Carboplatin—brain cancer	0.00186	0.0052	CcSEcCtD
Orlistat—Breast disorder—Hydroxyurea—brain cancer	0.00186	0.0052	CcSEcCtD
Orlistat—Haemoglobin—Procarbazine—brain cancer	0.00184	0.00517	CcSEcCtD
Orlistat—Haemorrhage—Procarbazine—brain cancer	0.00184	0.00515	CcSEcCtD
Orlistat—Decreased appetite—Lomustine—brain cancer	0.00179	0.00501	CcSEcCtD
Orlistat—Hepatic failure—Temozolomide—brain cancer	0.00178	0.005	CcSEcCtD
Orlistat—Pancreatitis—Hydroxyurea—brain cancer	0.00174	0.00488	CcSEcCtD
Orlistat—Menopausal symptoms—Temozolomide—brain cancer	0.0017	0.00477	CcSEcCtD
Orlistat—Thirst—Temozolomide—brain cancer	0.00169	0.00472	CcSEcCtD
Orlistat—PLA2G4A—brain—brain cancer	0.00164	0.00638	CbGeAlD
Orlistat—Body temperature increased—Lomustine—brain cancer	0.00162	0.00455	CcSEcCtD
Orlistat—Alopecia—Procarbazine—brain cancer	0.00162	0.00455	CcSEcCtD
Orlistat—Infestation NOS—Hydroxyurea—brain cancer	0.00158	0.00444	CcSEcCtD
Orlistat—Infestation—Hydroxyurea—brain cancer	0.00158	0.00444	CcSEcCtD
Orlistat—Neuropathy peripheral—Hydroxyurea—brain cancer	0.00155	0.00435	CcSEcCtD
Orlistat—Hypokalaemia—Carmustine—brain cancer	0.00151	0.00423	CcSEcCtD
Orlistat—Hepatobiliary disease—Hydroxyurea—brain cancer	0.0015	0.0042	CcSEcCtD
Orlistat—Dry skin—Temozolomide—brain cancer	0.00147	0.00412	CcSEcCtD
Orlistat—Hypokalaemia—Temozolomide—brain cancer	0.00146	0.00409	CcSEcCtD
Orlistat—Breast disorder—Temozolomide—brain cancer	0.00145	0.00406	CcSEcCtD
Orlistat—Haemoglobin—Hydroxyurea—brain cancer	0.00143	0.004	CcSEcCtD
Orlistat—Haemorrhage—Hydroxyurea—brain cancer	0.00142	0.00398	CcSEcCtD
Orlistat—Abdominal distension—Temozolomide—brain cancer	0.0014	0.00391	CcSEcCtD
Orlistat—Cough—Procarbazine—brain cancer	0.00139	0.00391	CcSEcCtD
Orlistat—Convulsion—Procarbazine—brain cancer	0.00138	0.00388	CcSEcCtD
Orlistat—Myalgia—Procarbazine—brain cancer	0.00136	0.00381	CcSEcCtD
Orlistat—Anxiety—Procarbazine—brain cancer	0.00136	0.0038	CcSEcCtD
Orlistat—Sweating increased—Temozolomide—brain cancer	0.00135	0.00379	CcSEcCtD
Orlistat—Dry mouth—Procarbazine—brain cancer	0.00133	0.00373	CcSEcCtD
Orlistat—Vomiting—Lomustine—brain cancer	0.00131	0.00366	CcSEcCtD
Orlistat—Oedema—Procarbazine—brain cancer	0.0013	0.00366	CcSEcCtD
Orlistat—Infection—Procarbazine—brain cancer	0.0013	0.00363	CcSEcCtD
Orlistat—Upper respiratory tract infection—Temozolomide—brain cancer	0.00129	0.00361	CcSEcCtD
Orlistat—Depression—Carmustine—brain cancer	0.00128	0.00358	CcSEcCtD
Orlistat—Hyperhidrosis—Procarbazine—brain cancer	0.00126	0.00353	CcSEcCtD
Orlistat—Renal failure—Carmustine—brain cancer	0.00126	0.00352	CcSEcCtD
Orlistat—Alopecia—Hydroxyurea—brain cancer	0.00125	0.00352	CcSEcCtD
Orlistat—Neuropathy peripheral—Carmustine—brain cancer	0.00125	0.00351	CcSEcCtD
Orlistat—Urinary tract infection—Carmustine—brain cancer	0.00124	0.00349	CcSEcCtD
Orlistat—Infestation NOS—Temozolomide—brain cancer	0.00124	0.00347	CcSEcCtD
Orlistat—Infestation—Temozolomide—brain cancer	0.00124	0.00347	CcSEcCtD
Orlistat—Depression—Temozolomide—brain cancer	0.00123	0.00346	CcSEcCtD
Orlistat—Nausea—Lomustine—brain cancer	0.00122	0.00342	CcSEcCtD
Orlistat—Neuropathy peripheral—Temozolomide—brain cancer	0.00121	0.0034	CcSEcCtD
Orlistat—Urinary tract infection—Temozolomide—brain cancer	0.0012	0.00337	CcSEcCtD
Orlistat—Musculoskeletal discomfort—Procarbazine—brain cancer	0.00119	0.00333	CcSEcCtD
Orlistat—Insomnia—Procarbazine—brain cancer	0.00118	0.00331	CcSEcCtD
Orlistat—Paraesthesia—Procarbazine—brain cancer	0.00117	0.00328	CcSEcCtD
Orlistat—Hepatobiliary disease—Temozolomide—brain cancer	0.00117	0.00328	CcSEcCtD
Orlistat—Sinusitis—Temozolomide—brain cancer	0.00116	0.00325	CcSEcCtD
Orlistat—Cramp muscle—Etoposide—brain cancer	0.00116	0.00324	CcSEcCtD
Orlistat—Haemoglobin—Carmustine—brain cancer	0.00115	0.00324	CcSEcCtD
Orlistat—Haemorrhage—Carmustine—brain cancer	0.00115	0.00322	CcSEcCtD
Orlistat—Ill-defined disorder—Hydroxyurea—brain cancer	0.00115	0.00322	CcSEcCtD
Orlistat—Decreased appetite—Procarbazine—brain cancer	0.00113	0.00318	CcSEcCtD
Orlistat—Oedema peripheral—Carmustine—brain cancer	0.00113	0.00317	CcSEcCtD
Orlistat—Fatigue—Procarbazine—brain cancer	0.00112	0.00315	CcSEcCtD
Orlistat—Haemoglobin—Temozolomide—brain cancer	0.00112	0.00313	CcSEcCtD
Orlistat—Malaise—Hydroxyurea—brain cancer	0.00111	0.00313	CcSEcCtD
Orlistat—Pain—Procarbazine—brain cancer	0.00111	0.00313	CcSEcCtD
Orlistat—Hepatitis—Temozolomide—brain cancer	0.00111	0.00311	CcSEcCtD
Orlistat—Haemorrhage—Temozolomide—brain cancer	0.00111	0.00311	CcSEcCtD
Orlistat—Pharyngitis—Temozolomide—brain cancer	0.0011	0.00309	CcSEcCtD
Orlistat—Urinary tract disorder—Temozolomide—brain cancer	0.0011	0.00307	CcSEcCtD
Orlistat—Oedema peripheral—Temozolomide—brain cancer	0.00109	0.00306	CcSEcCtD
Orlistat—Bronchospasm—Etoposide—brain cancer	0.00109	0.00306	CcSEcCtD
Orlistat—Urethral disorder—Temozolomide—brain cancer	0.00109	0.00305	CcSEcCtD
Orlistat—Sweating increased—Etoposide—brain cancer	0.00108	0.00303	CcSEcCtD
Orlistat—Feeling abnormal—Procarbazine—brain cancer	0.00107	0.00301	CcSEcCtD
Orlistat—Convulsion—Hydroxyurea—brain cancer	0.00107	0.003	CcSEcCtD
Orlistat—Gastrointestinal pain—Procarbazine—brain cancer	0.00107	0.00299	CcSEcCtD
Orlistat—Unspecified disorder of skin and subcutaneous tissue—Hydroxyurea—brain cancer	0.00105	0.00293	CcSEcCtD
Orlistat—Discomfort—Hydroxyurea—brain cancer	0.00104	0.00292	CcSEcCtD
Orlistat—Urticaria—Procarbazine—brain cancer	0.00104	0.0029	CcSEcCtD
Orlistat—Abdominal pain—Procarbazine—brain cancer	0.00103	0.00289	CcSEcCtD
Orlistat—Body temperature increased—Procarbazine—brain cancer	0.00103	0.00289	CcSEcCtD
Orlistat—Alopecia—Carmustine—brain cancer	0.00101	0.00284	CcSEcCtD
Orlistat—Oedema—Hydroxyurea—brain cancer	0.00101	0.00283	CcSEcCtD
Orlistat—Mental disorder—Carmustine—brain cancer	0.00101	0.00282	CcSEcCtD
Orlistat—Infection—Hydroxyurea—brain cancer	0.001	0.00281	CcSEcCtD
Orlistat—Immune system disorder—Temozolomide—brain cancer	0.001	0.00281	CcSEcCtD
Orlistat—Mediastinal disorder—Temozolomide—brain cancer	0.001	0.0028	CcSEcCtD
Orlistat—Malnutrition—Carmustine—brain cancer	0.000999	0.0028	CcSEcCtD
Orlistat—Nervous system disorder—Hydroxyurea—brain cancer	0.000989	0.00277	CcSEcCtD
Orlistat—Infestation NOS—Etoposide—brain cancer	0.000989	0.00277	CcSEcCtD
Orlistat—Infestation—Etoposide—brain cancer	0.000989	0.00277	CcSEcCtD
Orlistat—Alopecia—Temozolomide—brain cancer	0.00098	0.00275	CcSEcCtD
Orlistat—Skin disorder—Hydroxyurea—brain cancer	0.00098	0.00275	CcSEcCtD
Orlistat—Renal failure—Etoposide—brain cancer	0.000972	0.00273	CcSEcCtD
Orlistat—Mental disorder—Temozolomide—brain cancer	0.000972	0.00273	CcSEcCtD
Orlistat—Neuropathy peripheral—Etoposide—brain cancer	0.000969	0.00272	CcSEcCtD
Orlistat—Back pain—Carmustine—brain cancer	0.000967	0.00271	CcSEcCtD
Orlistat—Malnutrition—Temozolomide—brain cancer	0.000966	0.00271	CcSEcCtD
Orlistat—Hypersensitivity—Procarbazine—brain cancer	0.000961	0.00269	CcSEcCtD
Orlistat—Dysgeusia—Temozolomide—brain cancer	0.000946	0.00265	CcSEcCtD
Orlistat—Vision blurred—Carmustine—brain cancer	0.000942	0.00264	CcSEcCtD
Orlistat—Asthenia—Procarbazine—brain cancer	0.000935	0.00262	CcSEcCtD
Orlistat—Hepatobiliary disease—Etoposide—brain cancer	0.000935	0.00262	CcSEcCtD
Orlistat—Back pain—Temozolomide—brain cancer	0.000934	0.00262	CcSEcCtD
Orlistat—Pruritus—Procarbazine—brain cancer	0.000922	0.00259	CcSEcCtD
Orlistat—Vision blurred—Temozolomide—brain cancer	0.00091	0.00255	CcSEcCtD
Orlistat—Ill-defined disorder—Temozolomide—brain cancer	0.000896	0.00251	CcSEcCtD
Orlistat—Diarrhoea—Procarbazine—brain cancer	0.000892	0.0025	CcSEcCtD
Orlistat—Dyspepsia—Hydroxyurea—brain cancer	0.000888	0.00249	CcSEcCtD
Orlistat—Angioedema—Temozolomide—brain cancer	0.000882	0.00247	CcSEcCtD
Orlistat—Decreased appetite—Hydroxyurea—brain cancer	0.000877	0.00246	CcSEcCtD
Orlistat—Urinary tract disorder—Etoposide—brain cancer	0.000877	0.00246	CcSEcCtD
Orlistat—Gastrointestinal disorder—Hydroxyurea—brain cancer	0.000871	0.00244	CcSEcCtD
Orlistat—Malaise—Temozolomide—brain cancer	0.000871	0.00244	CcSEcCtD
Orlistat—Urethral disorder—Etoposide—brain cancer	0.00087	0.00244	CcSEcCtD
Orlistat—Fatigue—Hydroxyurea—brain cancer	0.00087	0.00244	CcSEcCtD
Orlistat—Vertigo—Temozolomide—brain cancer	0.000868	0.00243	CcSEcCtD
Orlistat—Convulsion—Carmustine—brain cancer	0.000866	0.00243	CcSEcCtD
Orlistat—Pain—Hydroxyurea—brain cancer	0.000863	0.00242	CcSEcCtD
Orlistat—Dizziness—Procarbazine—brain cancer	0.000862	0.00242	CcSEcCtD
Orlistat—Palpitations—Temozolomide—brain cancer	0.000853	0.00239	CcSEcCtD
Orlistat—Chest pain—Carmustine—brain cancer	0.000851	0.00239	CcSEcCtD
Orlistat—Myalgia—Carmustine—brain cancer	0.000851	0.00239	CcSEcCtD
Orlistat—Anxiety—Carmustine—brain cancer	0.000848	0.00238	CcSEcCtD
Orlistat—Cough—Temozolomide—brain cancer	0.000843	0.00236	CcSEcCtD
Orlistat—Convulsion—Temozolomide—brain cancer	0.000837	0.00235	CcSEcCtD
Orlistat—Feeling abnormal—Hydroxyurea—brain cancer	0.000831	0.00233	CcSEcCtD
Orlistat—Vomiting—Procarbazine—brain cancer	0.000829	0.00232	CcSEcCtD
Orlistat—Myalgia—Temozolomide—brain cancer	0.000822	0.00231	CcSEcCtD
Orlistat—Rash—Procarbazine—brain cancer	0.000822	0.0023	CcSEcCtD
Orlistat—Dermatitis—Procarbazine—brain cancer	0.000821	0.0023	CcSEcCtD
Orlistat—Anxiety—Temozolomide—brain cancer	0.000819	0.0023	CcSEcCtD
Orlistat—Headache—Procarbazine—brain cancer	0.000817	0.00229	CcSEcCtD
Orlistat—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—brain cancer	0.000817	0.00229	CcSEcCtD
Orlistat—Oedema—Carmustine—brain cancer	0.000816	0.00229	CcSEcCtD
Orlistat—Discomfort—Temozolomide—brain cancer	0.000812	0.00228	CcSEcCtD
Orlistat—Infection—Carmustine—brain cancer	0.00081	0.00227	CcSEcCtD
Orlistat—Dry mouth—Temozolomide—brain cancer	0.000804	0.00225	CcSEcCtD
Orlistat—Immune system disorder—Etoposide—brain cancer	0.000802	0.00225	CcSEcCtD
Orlistat—Mediastinal disorder—Etoposide—brain cancer	0.0008	0.00224	CcSEcCtD
Orlistat—Body temperature increased—Hydroxyurea—brain cancer	0.000798	0.00224	CcSEcCtD
Orlistat—Anaphylactic shock—Temozolomide—brain cancer	0.000788	0.00221	CcSEcCtD
Orlistat—Oedema—Temozolomide—brain cancer	0.000788	0.00221	CcSEcCtD
Orlistat—Alopecia—Etoposide—brain cancer	0.000785	0.0022	CcSEcCtD
Orlistat—Infection—Temozolomide—brain cancer	0.000783	0.0022	CcSEcCtD
Orlistat—Nausea—Procarbazine—brain cancer	0.000774	0.00217	CcSEcCtD
Orlistat—Nervous system disorder—Temozolomide—brain cancer	0.000773	0.00217	CcSEcCtD
Orlistat—Skin disorder—Temozolomide—brain cancer	0.000766	0.00215	CcSEcCtD
Orlistat—Hyperhidrosis—Temozolomide—brain cancer	0.000762	0.00214	CcSEcCtD
Orlistat—Dysgeusia—Etoposide—brain cancer	0.000757	0.00212	CcSEcCtD
Orlistat—CYP3A4—endocrine gland—brain cancer	0.000754	0.00294	CbGeAlD
Orlistat—Back pain—Etoposide—brain cancer	0.000748	0.0021	CcSEcCtD
Orlistat—Hypersensitivity—Hydroxyurea—brain cancer	0.000743	0.00208	CcSEcCtD
Orlistat—Musculoskeletal discomfort—Carmustine—brain cancer	0.000743	0.00208	CcSEcCtD
Orlistat—Muscle spasms—Etoposide—brain cancer	0.000743	0.00208	CcSEcCtD
Orlistat—Insomnia—Carmustine—brain cancer	0.000738	0.00207	CcSEcCtD
Orlistat—Paraesthesia—Carmustine—brain cancer	0.000732	0.00205	CcSEcCtD
Orlistat—Asthenia—Hydroxyurea—brain cancer	0.000724	0.00203	CcSEcCtD
Orlistat—Musculoskeletal discomfort—Temozolomide—brain cancer	0.000718	0.00201	CcSEcCtD
Orlistat—Ill-defined disorder—Etoposide—brain cancer	0.000717	0.00201	CcSEcCtD
Orlistat—Insomnia—Temozolomide—brain cancer	0.000713	0.002	CcSEcCtD
Orlistat—Decreased appetite—Carmustine—brain cancer	0.000709	0.00199	CcSEcCtD
Orlistat—Paraesthesia—Temozolomide—brain cancer	0.000708	0.00198	CcSEcCtD
Orlistat—Gastrointestinal disorder—Carmustine—brain cancer	0.000704	0.00197	CcSEcCtD
Orlistat—Pain—Carmustine—brain cancer	0.000697	0.00196	CcSEcCtD
Orlistat—Malaise—Etoposide—brain cancer	0.000697	0.00195	CcSEcCtD
Orlistat—Vertigo—Etoposide—brain cancer	0.000694	0.00195	CcSEcCtD
Orlistat—Dyspepsia—Temozolomide—brain cancer	0.000694	0.00195	CcSEcCtD
Orlistat—Diarrhoea—Hydroxyurea—brain cancer	0.00069	0.00194	CcSEcCtD
Orlistat—Decreased appetite—Temozolomide—brain cancer	0.000685	0.00192	CcSEcCtD
Orlistat—Gastrointestinal disorder—Temozolomide—brain cancer	0.00068	0.00191	CcSEcCtD
Orlistat—CYP3A4—central nervous system—brain cancer	0.00068	0.00265	CbGeAlD
Orlistat—Fatigue—Temozolomide—brain cancer	0.00068	0.00191	CcSEcCtD
Orlistat—Cough—Etoposide—brain cancer	0.000674	0.00189	CcSEcCtD
Orlistat—Pain—Temozolomide—brain cancer	0.000674	0.00189	CcSEcCtD
Orlistat—Feeling abnormal—Carmustine—brain cancer	0.000672	0.00188	CcSEcCtD
Orlistat—Convulsion—Etoposide—brain cancer	0.00067	0.00188	CcSEcCtD
Orlistat—Dizziness—Hydroxyurea—brain cancer	0.000667	0.00187	CcSEcCtD
Orlistat—Gastrointestinal pain—Carmustine—brain cancer	0.000667	0.00187	CcSEcCtD
Orlistat—Chest pain—Etoposide—brain cancer	0.000658	0.00184	CcSEcCtD
Orlistat—Unspecified disorder of skin and subcutaneous tissue—Etoposide—brain cancer	0.000653	0.00183	CcSEcCtD
Orlistat—Discomfort—Etoposide—brain cancer	0.00065	0.00182	CcSEcCtD
Orlistat—Feeling abnormal—Temozolomide—brain cancer	0.00065	0.00182	CcSEcCtD
Orlistat—Body temperature increased—Carmustine—brain cancer	0.000645	0.00181	CcSEcCtD
Orlistat—Abdominal pain—Carmustine—brain cancer	0.000645	0.00181	CcSEcCtD
Orlistat—Gastrointestinal pain—Temozolomide—brain cancer	0.000645	0.00181	CcSEcCtD
Orlistat—Vomiting—Hydroxyurea—brain cancer	0.000642	0.0018	CcSEcCtD
Orlistat—Rash—Hydroxyurea—brain cancer	0.000636	0.00178	CcSEcCtD
Orlistat—Dermatitis—Hydroxyurea—brain cancer	0.000636	0.00178	CcSEcCtD
Orlistat—Headache—Hydroxyurea—brain cancer	0.000632	0.00177	CcSEcCtD
Orlistat—Anaphylactic shock—Etoposide—brain cancer	0.000631	0.00177	CcSEcCtD
Orlistat—Infection—Etoposide—brain cancer	0.000627	0.00176	CcSEcCtD
Orlistat—Urticaria—Temozolomide—brain cancer	0.000626	0.00176	CcSEcCtD
Orlistat—Body temperature increased—Temozolomide—brain cancer	0.000623	0.00175	CcSEcCtD
Orlistat—Abdominal pain—Temozolomide—brain cancer	0.000623	0.00175	CcSEcCtD
Orlistat—Skin disorder—Etoposide—brain cancer	0.000613	0.00172	CcSEcCtD
Orlistat—Hyperhidrosis—Etoposide—brain cancer	0.00061	0.00171	CcSEcCtD
Orlistat—Hypersensitivity—Carmustine—brain cancer	0.000601	0.00168	CcSEcCtD
Orlistat—Nausea—Hydroxyurea—brain cancer	0.000599	0.00168	CcSEcCtD
Orlistat—Asthenia—Carmustine—brain cancer	0.000585	0.00164	CcSEcCtD
Orlistat—Hypersensitivity—Temozolomide—brain cancer	0.000581	0.00163	CcSEcCtD
Orlistat—DAGLA—Signaling Pathways—GLI2—brain cancer	0.00058	0.00215	CbGpPWpGaD
Orlistat—PNLIP—Metabolism—BSG—brain cancer	0.000575	0.00213	CbGpPWpGaD
Orlistat—PLA2G4A—Fc-epsilon receptor I signaling in mast cells—RELA—brain cancer	0.00057	0.00211	CbGpPWpGaD
Orlistat—DAGLA—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—brain cancer	0.00057	0.00211	CbGpPWpGaD
Orlistat—DAGLB—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—brain cancer	0.00057	0.00211	CbGpPWpGaD
Orlistat—Paraesthesia—Etoposide—brain cancer	0.000566	0.00159	CcSEcCtD
Orlistat—Asthenia—Temozolomide—brain cancer	0.000566	0.00159	CcSEcCtD
Orlistat—PNLIP—Disease—HEY1—brain cancer	0.00056	0.00208	CbGpPWpGaD
Orlistat—Diarrhoea—Carmustine—brain cancer	0.000558	0.00156	CcSEcCtD
Orlistat—Pruritus—Temozolomide—brain cancer	0.000558	0.00156	CcSEcCtD
Orlistat—CYP3A4—Irinotecan Pathway—APC—brain cancer	0.000555	0.00206	CbGpPWpGaD
Orlistat—PNLIP—Disease—DLL1—brain cancer	0.000549	0.00204	CbGpPWpGaD
Orlistat—Decreased appetite—Etoposide—brain cancer	0.000548	0.00154	CcSEcCtD
Orlistat—PLA2G4A—Platelet activation, signaling and aggregation—TRPC6—brain cancer	0.000548	0.00203	CbGpPWpGaD
Orlistat—DAGLA—Signaling Pathways—GLI1—brain cancer	0.000546	0.00202	CbGpPWpGaD
Orlistat—DAGLB—Signaling Pathways—GLI1—brain cancer	0.000546	0.00202	CbGpPWpGaD
Orlistat—Gastrointestinal disorder—Etoposide—brain cancer	0.000545	0.00153	CcSEcCtD
Orlistat—Fatigue—Etoposide—brain cancer	0.000544	0.00152	CcSEcCtD
Orlistat—Dizziness—Carmustine—brain cancer	0.000539	0.00151	CcSEcCtD
Orlistat—Pain—Etoposide—brain cancer	0.000539	0.00151	CcSEcCtD
Orlistat—Diarrhoea—Temozolomide—brain cancer	0.000539	0.00151	CcSEcCtD
Orlistat—PLA2G4A—AGE/RAGE pathway—RELA—brain cancer	0.000535	0.00199	CbGpPWpGaD
Orlistat—DAGLB—Hemostasis—PIK3CG—brain cancer	0.000534	0.00198	CbGpPWpGaD
Orlistat—DAGLA—Hemostasis—PIK3CG—brain cancer	0.000534	0.00198	CbGpPWpGaD
Orlistat—DAGLB—GPCR downstream signaling—VAV1—brain cancer	0.000531	0.00197	CbGpPWpGaD
Orlistat—DAGLA—GPCR downstream signaling—VAV1—brain cancer	0.000531	0.00197	CbGpPWpGaD
Orlistat—CYP3A4—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.000529	0.00196	CbGpPWpGaD
Orlistat—Dizziness—Temozolomide—brain cancer	0.000521	0.00146	CcSEcCtD
Orlistat—Feeling abnormal—Etoposide—brain cancer	0.00052	0.00146	CcSEcCtD
Orlistat—Vomiting—Carmustine—brain cancer	0.000519	0.00145	CcSEcCtD
Orlistat—DAGLB—Signaling Pathways—SUFU—brain cancer	0.000517	0.00192	CbGpPWpGaD
Orlistat—DAGLA—Signaling Pathways—SUFU—brain cancer	0.000517	0.00192	CbGpPWpGaD
Orlistat—Gastrointestinal pain—Etoposide—brain cancer	0.000516	0.00145	CcSEcCtD
Orlistat—Rash—Carmustine—brain cancer	0.000514	0.00144	CcSEcCtD
Orlistat—PLA2G4A—Signaling mediated by p38-alpha and p38-beta—TP53—brain cancer	0.000514	0.00191	CbGpPWpGaD
Orlistat—Dermatitis—Carmustine—brain cancer	0.000514	0.00144	CcSEcCtD
Orlistat—Headache—Carmustine—brain cancer	0.000511	0.00143	CcSEcCtD
Orlistat—PLA2G4A—Integrated Pancreatic Cancer Pathway—ESR2—brain cancer	0.000511	0.00189	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling by GPCR—OR4C12—brain cancer	0.000506	0.00188	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling by GPCR—OR14C36—brain cancer	0.000506	0.00188	CbGpPWpGaD
Orlistat—Vomiting—Temozolomide—brain cancer	0.000501	0.00141	CcSEcCtD
Orlistat—Urticaria—Etoposide—brain cancer	0.000501	0.0014	CcSEcCtD
Orlistat—DAGLB—Signaling Pathways—GFAP—brain cancer	0.000499	0.00185	CbGpPWpGaD
Orlistat—DAGLA—Signaling Pathways—GFAP—brain cancer	0.000499	0.00185	CbGpPWpGaD
Orlistat—Body temperature increased—Etoposide—brain cancer	0.000499	0.0014	CcSEcCtD
Orlistat—Abdominal pain—Etoposide—brain cancer	0.000499	0.0014	CcSEcCtD
Orlistat—PNLIP—Signaling Pathways—ABR—brain cancer	0.000498	0.00185	CbGpPWpGaD
Orlistat—Rash—Temozolomide—brain cancer	0.000497	0.00139	CcSEcCtD
Orlistat—Dermatitis—Temozolomide—brain cancer	0.000497	0.00139	CcSEcCtD
Orlistat—PNLIP—Metabolism—IDH1—brain cancer	0.000494	0.00183	CbGpPWpGaD
Orlistat—Headache—Temozolomide—brain cancer	0.000494	0.00138	CcSEcCtD
Orlistat—CYP3A4—Farnesoid X Receptor  Pathway—IRS2—brain cancer	0.000492	0.00182	CbGpPWpGaD
Orlistat—Nausea—Carmustine—brain cancer	0.000484	0.00136	CcSEcCtD
Orlistat—DAGLB—Signaling by GPCR—VAV1—brain cancer	0.000482	0.00179	CbGpPWpGaD
Orlistat—DAGLA—Signaling by GPCR—VAV1—brain cancer	0.000482	0.00179	CbGpPWpGaD
Orlistat—PNLIP—Signaling Pathways—GLI2—brain cancer	0.000481	0.00178	CbGpPWpGaD
Orlistat—FASN—Metabolism—CYP2C9—brain cancer	0.000478	0.00177	CbGpPWpGaD
Orlistat—DAGLB—Signaling Pathways—HEY1—brain cancer	0.000473	0.00175	CbGpPWpGaD
Orlistat—DAGLA—Signaling Pathways—HEY1—brain cancer	0.000473	0.00175	CbGpPWpGaD
Orlistat—Nausea—Temozolomide—brain cancer	0.000468	0.00131	CcSEcCtD
Orlistat—PNLIP—Disease—ENO2—brain cancer	0.000467	0.00173	CbGpPWpGaD
Orlistat—PNLIP—Disease—SHH—brain cancer	0.000467	0.00173	CbGpPWpGaD
Orlistat—Hypersensitivity—Etoposide—brain cancer	0.000465	0.0013	CcSEcCtD
Orlistat—DAGLA—Signaling Pathways—DLL1—brain cancer	0.000464	0.00172	CbGpPWpGaD
Orlistat—DAGLB—Signaling Pathways—DLL1—brain cancer	0.000464	0.00172	CbGpPWpGaD
Orlistat—PLA2G4A—Metabolism of lipids and lipoproteins—CYP2C9—brain cancer	0.000461	0.00171	CbGpPWpGaD
Orlistat—Asthenia—Etoposide—brain cancer	0.000453	0.00127	CcSEcCtD
Orlistat—PNLIP—Signaling Pathways—GLI1—brain cancer	0.000452	0.00168	CbGpPWpGaD
Orlistat—Pruritus—Etoposide—brain cancer	0.000446	0.00125	CcSEcCtD
Orlistat—Diarrhoea—Etoposide—brain cancer	0.000432	0.00121	CcSEcCtD
Orlistat—PLA2G4A—Hemostasis—BSG—brain cancer	0.000431	0.0016	CbGpPWpGaD
Orlistat—PNLIP—Signaling Pathways—SUFU—brain cancer	0.000429	0.00159	CbGpPWpGaD
Orlistat—PLA2G4A—Integrated Pancreatic Cancer Pathway—BRCA2—brain cancer	0.000419	0.00156	CbGpPWpGaD
Orlistat—FASN—Disease—IDH1—brain cancer	0.000418	0.00155	CbGpPWpGaD
Orlistat—Dizziness—Etoposide—brain cancer	0.000417	0.00117	CcSEcCtD
Orlistat—PNLIP—Signaling Pathways—GFAP—brain cancer	0.000413	0.00153	CbGpPWpGaD
Orlistat—PLA2G4A—Integrated Pancreatic Cancer Pathway—SIRT1—brain cancer	0.000411	0.00153	CbGpPWpGaD
Orlistat—PLA2G4A—PDGFR-beta signaling pathway—PIK3CG—brain cancer	0.000411	0.00152	CbGpPWpGaD
Orlistat—PLA2G4A—Platelet activation, signaling and aggregation—VAV1—brain cancer	0.00041	0.00152	CbGpPWpGaD
Orlistat—FASN—Metabolism—BSG—brain cancer	0.000407	0.00151	CbGpPWpGaD
Orlistat—PLA2G4A—Integrated Pancreatic Cancer Pathway—CCNE1—brain cancer	0.000406	0.00151	CbGpPWpGaD
Orlistat—PLA2G4A—AGE/RAGE pathway—STAT3—brain cancer	0.000406	0.0015	CbGpPWpGaD
Orlistat—PNLIP—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	0.000403	0.00149	CbGpPWpGaD
Orlistat—Vomiting—Etoposide—brain cancer	0.000401	0.00112	CcSEcCtD
Orlistat—Rash—Etoposide—brain cancer	0.000398	0.00112	CcSEcCtD
Orlistat—Dermatitis—Etoposide—brain cancer	0.000397	0.00111	CcSEcCtD
Orlistat—FASN—Disease—HEY1—brain cancer	0.000396	0.00147	CbGpPWpGaD
Orlistat—Headache—Etoposide—brain cancer	0.000395	0.00111	CcSEcCtD
Orlistat—DAGLB—Signaling Pathways—SHH—brain cancer	0.000394	0.00146	CbGpPWpGaD
Orlistat—DAGLA—Signaling Pathways—SHH—brain cancer	0.000394	0.00146	CbGpPWpGaD
Orlistat—PNLIP—Signaling Pathways—HEY1—brain cancer	0.000392	0.00145	CbGpPWpGaD
Orlistat—PNLIP—Metabolism—ENO2—brain cancer	0.000391	0.00145	CbGpPWpGaD
Orlistat—FASN—Disease—DLL1—brain cancer	0.000388	0.00144	CbGpPWpGaD
Orlistat—PNLIP—Signaling Pathways—DLL1—brain cancer	0.000384	0.00143	CbGpPWpGaD
Orlistat—DAGLB—Signaling Pathways—TRPC6—brain cancer	0.00038	0.00141	CbGpPWpGaD
Orlistat—DAGLA—Signaling Pathways—TRPC6—brain cancer	0.00038	0.00141	CbGpPWpGaD
Orlistat—PLA2G4A—Phospholipid metabolism—PIK3CG—brain cancer	0.00038	0.00141	CbGpPWpGaD
Orlistat—PLA2G4A—Integrated Pancreatic Cancer Pathway—PDGFRA—brain cancer	0.000378	0.0014	CbGpPWpGaD
Orlistat—PLA2G7—Metabolism of proteins—CTNNB1—brain cancer	0.000376	0.0014	CbGpPWpGaD
Orlistat—DAGLB—Hemostasis—IL2—brain cancer	0.000376	0.00139	CbGpPWpGaD
Orlistat—DAGLA—Hemostasis—IL2—brain cancer	0.000376	0.00139	CbGpPWpGaD
Orlistat—Nausea—Etoposide—brain cancer	0.000375	0.00105	CcSEcCtD
Orlistat—DAGLA—Signaling Pathways—PTCH1—brain cancer	0.000374	0.00139	CbGpPWpGaD
Orlistat—DAGLB—Signaling Pathways—PTCH1—brain cancer	0.000374	0.00139	CbGpPWpGaD
Orlistat—DAGLA—Signaling Pathways—SMO—brain cancer	0.000374	0.00139	CbGpPWpGaD
Orlistat—DAGLB—Signaling Pathways—SMO—brain cancer	0.000374	0.00139	CbGpPWpGaD
Orlistat—PLA2G4A—AGE/RAGE pathway—EGFR—brain cancer	0.000369	0.00137	CbGpPWpGaD
Orlistat—PLA2G4A—Integrated Pancreatic Cancer Pathway—PCNA—brain cancer	0.00036	0.00133	CbGpPWpGaD
Orlistat—FASN—Metabolism—IDH1—brain cancer	0.00035	0.0013	CbGpPWpGaD
Orlistat—DAGLA—GPCR downstream signaling—PIK3CG—brain cancer	0.000337	0.00125	CbGpPWpGaD
Orlistat—DAGLB—GPCR downstream signaling—PIK3CG—brain cancer	0.000337	0.00125	CbGpPWpGaD
Orlistat—PNLIP—Disease—VAV1—brain cancer	0.000337	0.00125	CbGpPWpGaD
Orlistat—PLA2G4A—Metabolism of lipids and lipoproteins—IDH1—brain cancer	0.000337	0.00125	CbGpPWpGaD
Orlistat—FASN—Disease—ENO2—brain cancer	0.00033	0.00122	CbGpPWpGaD
Orlistat—FASN—Disease—SHH—brain cancer	0.00033	0.00122	CbGpPWpGaD
Orlistat—PNLIP—Signaling Pathways—SHH—brain cancer	0.000327	0.00121	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling by GPCR—PTCH2—brain cancer	0.000326	0.00121	CbGpPWpGaD
Orlistat—DAGLB—Hemostasis—VEGFA—brain cancer	0.000319	0.00118	CbGpPWpGaD
Orlistat—DAGLA—Hemostasis—VEGFA—brain cancer	0.000319	0.00118	CbGpPWpGaD
Orlistat—PNLIP—Signaling Pathways—TRPC6—brain cancer	0.000315	0.00117	CbGpPWpGaD
Orlistat—PLA2G4A—Integrated Pancreatic Cancer Pathway—CDK4—brain cancer	0.000311	0.00115	CbGpPWpGaD
Orlistat—PNLIP—Signaling Pathways—SMO—brain cancer	0.00031	0.00115	CbGpPWpGaD
Orlistat—PNLIP—Signaling Pathways—PTCH1—brain cancer	0.00031	0.00115	CbGpPWpGaD
Orlistat—DAGLB—Signaling by GPCR—PIK3CG—brain cancer	0.000306	0.00114	CbGpPWpGaD
Orlistat—DAGLA—Signaling by GPCR—PIK3CG—brain cancer	0.000306	0.00114	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—OR4C12—brain cancer	0.000299	0.00111	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—OR14C36—brain cancer	0.000299	0.00111	CbGpPWpGaD
Orlistat—DAGLB—Signaling Pathways—NOTCH2—brain cancer	0.000299	0.00111	CbGpPWpGaD
Orlistat—DAGLA—Signaling Pathways—NOTCH2—brain cancer	0.000299	0.00111	CbGpPWpGaD
Orlistat—PLA2G4A—Integrated Pancreatic Cancer Pathway—APC—brain cancer	0.000293	0.00109	CbGpPWpGaD
Orlistat—PNLIP—Disease—HES1—brain cancer	0.00029	0.00108	CbGpPWpGaD
Orlistat—DAGLA—Signaling Pathways—VAV1—brain cancer	0.000285	0.00106	CbGpPWpGaD
Orlistat—DAGLB—Signaling Pathways—VAV1—brain cancer	0.000285	0.00106	CbGpPWpGaD
Orlistat—FASN—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	0.000285	0.00106	CbGpPWpGaD
Orlistat—PLA2G4A—Hemostasis—TRPC6—brain cancer	0.000282	0.00105	CbGpPWpGaD
Orlistat—CYP3A4—Biological oxidations—CYP2C9—brain cancer	0.000281	0.00104	CbGpPWpGaD
Orlistat—CYP3A4—Metapathway biotransformation—CYP2C9—brain cancer	0.000277	0.00103	CbGpPWpGaD
Orlistat—FASN—Metabolism—ENO2—brain cancer	0.000277	0.00103	CbGpPWpGaD
Orlistat—PNLIP—Disease—PDGFRA—brain cancer	0.000276	0.00102	CbGpPWpGaD
Orlistat—PLA2G4A—Platelet activation, signaling and aggregation—PIK3CG—brain cancer	0.00026	0.000966	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling by GPCR—ABR—brain cancer	0.000256	0.000949	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—DTX2—brain cancer	0.000254	0.000943	CbGpPWpGaD
Orlistat—PNLIP—Signaling Pathways—NOTCH2—brain cancer	0.000248	0.000919	CbGpPWpGaD
Orlistat—DAGLB—Signaling Pathways—HES1—brain cancer	0.000245	0.000909	CbGpPWpGaD
Orlistat—DAGLA—Signaling Pathways—HES1—brain cancer	0.000245	0.000909	CbGpPWpGaD
Orlistat—PLA2G4A—PDGFR-beta signaling pathway—STAT3—brain cancer	0.000243	0.000903	CbGpPWpGaD
Orlistat—PNLIP—Disease—IRS2—brain cancer	0.000242	0.000899	CbGpPWpGaD
Orlistat—DAGLB—Hemostasis—TP53—brain cancer	0.000241	0.000895	CbGpPWpGaD
Orlistat—DAGLA—Hemostasis—TP53—brain cancer	0.000241	0.000895	CbGpPWpGaD
Orlistat—FASN—Disease—VAV1—brain cancer	0.000239	0.000885	CbGpPWpGaD
Orlistat—DAGLA—GPCR downstream signaling—IL2—brain cancer	0.000237	0.000881	CbGpPWpGaD
Orlistat—DAGLB—GPCR downstream signaling—IL2—brain cancer	0.000237	0.000881	CbGpPWpGaD
Orlistat—PNLIP—Signaling Pathways—VAV1—brain cancer	0.000236	0.000876	CbGpPWpGaD
Orlistat—DAGLB—Signaling Pathways—PDGFRA—brain cancer	0.000233	0.000866	CbGpPWpGaD
Orlistat—DAGLA—Signaling Pathways—PDGFRA—brain cancer	0.000233	0.000866	CbGpPWpGaD
Orlistat—PLA2G4A—Integrated Pancreatic Cancer Pathway—ERBB2—brain cancer	0.000227	0.000843	CbGpPWpGaD
Orlistat—DAGLB—Signaling Pathways—SPP1—brain cancer	0.000227	0.00084	CbGpPWpGaD
Orlistat—DAGLA—Signaling Pathways—SPP1—brain cancer	0.000227	0.00084	CbGpPWpGaD
Orlistat—PLA2G4A—PDGFR-beta signaling pathway—MYC—brain cancer	0.000226	0.000839	CbGpPWpGaD
Orlistat—DAGLA—Signaling by GPCR—IL2—brain cancer	0.000216	0.0008	CbGpPWpGaD
Orlistat—DAGLB—Signaling by GPCR—IL2—brain cancer	0.000216	0.0008	CbGpPWpGaD
Orlistat—PNLIP—Disease—APC—brain cancer	0.000214	0.000794	CbGpPWpGaD
Orlistat—PLA2G4A—Hemostasis—VAV1—brain cancer	0.000211	0.000784	CbGpPWpGaD
Orlistat—PLA2G4A—Metabolism—CYP2C9—brain cancer	0.000205	0.000762	CbGpPWpGaD
Orlistat—FASN—Disease—HES1—brain cancer	0.000205	0.000761	CbGpPWpGaD
Orlistat—DAGLA—Signaling Pathways—IRS2—brain cancer	0.000205	0.00076	CbGpPWpGaD
Orlistat—DAGLB—Signaling Pathways—IRS2—brain cancer	0.000205	0.00076	CbGpPWpGaD
Orlistat—PNLIP—Signaling Pathways—HES1—brain cancer	0.000203	0.000753	CbGpPWpGaD
Orlistat—PLA2G4A—Integrated Pancreatic Cancer Pathway—CCND1—brain cancer	0.000201	0.000745	CbGpPWpGaD
Orlistat—PLA2G4A—Integrated Pancreatic Cancer Pathway—CTNNB1—brain cancer	0.000199	0.000738	CbGpPWpGaD
Orlistat—FASN—Disease—PDGFRA—brain cancer	0.000195	0.000725	CbGpPWpGaD
Orlistat—PNLIP—Signaling Pathways—PDGFRA—brain cancer	0.000193	0.000717	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—PTCH2—brain cancer	0.000193	0.000715	CbGpPWpGaD
Orlistat—PNLIP—Signaling Pathways—SPP1—brain cancer	0.000188	0.000696	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—HES5—brain cancer	0.000187	0.000692	CbGpPWpGaD
Orlistat—PLA2G4A—Platelet activation, signaling and aggregation—IL2—brain cancer	0.000183	0.00068	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—STRADA—brain cancer	0.000181	0.000672	CbGpPWpGaD
Orlistat—DAGLA—Signaling Pathways—PIK3CG—brain cancer	0.000181	0.000671	CbGpPWpGaD
Orlistat—DAGLB—Signaling Pathways—PIK3CG—brain cancer	0.000181	0.000671	CbGpPWpGaD
Orlistat—DAGLA—Signaling Pathways—APC—brain cancer	0.000181	0.000671	CbGpPWpGaD
Orlistat—DAGLB—Signaling Pathways—APC—brain cancer	0.000181	0.000671	CbGpPWpGaD
Orlistat—PNLIP—Metabolism—PIK3CG—brain cancer	0.000179	0.000665	CbGpPWpGaD
Orlistat—PLA2G4A—Integrated Pancreatic Cancer Pathway—VEGFA—brain cancer	0.000175	0.000649	CbGpPWpGaD
Orlistat—PLA2G4A—Metabolism—BSG—brain cancer	0.000175	0.000648	CbGpPWpGaD
Orlistat—FASN—Disease—IRS2—brain cancer	0.000172	0.000636	CbGpPWpGaD
Orlistat—PNLIP—Signaling Pathways—IRS2—brain cancer	0.00017	0.00063	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling by GPCR—SHH—brain cancer	0.000168	0.000623	CbGpPWpGaD
Orlistat—PNLIP—Disease—ERBB2—brain cancer	0.000166	0.000617	CbGpPWpGaD
Orlistat—DAGLB—Signaling by GPCR—EGFR—brain cancer	0.000165	0.000612	CbGpPWpGaD
Orlistat—DAGLA—Signaling by GPCR—EGFR—brain cancer	0.000165	0.000612	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling by GPCR—TRPC6—brain cancer	0.000162	0.000601	CbGpPWpGaD
Orlistat—PLA2G4A—Integrated Pancreatic Cancer Pathway—MYC—brain cancer	0.000161	0.000598	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling by GPCR—SMO—brain cancer	0.000159	0.000591	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling by GPCR—PTCH1—brain cancer	0.000159	0.000591	CbGpPWpGaD
Orlistat—PLA2G4A—Integrated Pancreatic Cancer Pathway—EGFR—brain cancer	0.000158	0.000584	CbGpPWpGaD
Orlistat—PLA2G4A—Platelet activation, signaling and aggregation—VEGFA—brain cancer	0.000156	0.000578	CbGpPWpGaD
Orlistat—FASN—Disease—APC—brain cancer	0.000151	0.000562	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—ABR—brain cancer	0.000151	0.000561	CbGpPWpGaD
Orlistat—PLA2G4A—Metabolism—IDH1—brain cancer	0.00015	0.000557	CbGpPWpGaD
Orlistat—PNLIP—Signaling Pathways—PIK3CG—brain cancer	0.00015	0.000556	CbGpPWpGaD
Orlistat—PNLIP—Signaling Pathways—APC—brain cancer	0.00015	0.000556	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—GLI2—brain cancer	0.000146	0.000542	CbGpPWpGaD
Orlistat—PNLIP—Disease—CTNNB1—brain cancer	0.000145	0.00054	CbGpPWpGaD
Orlistat—DAGLB—Signaling Pathways—RELA—brain cancer	0.000141	0.000524	CbGpPWpGaD
Orlistat—DAGLA—Signaling Pathways—RELA—brain cancer	0.000141	0.000524	CbGpPWpGaD
Orlistat—DAGLA—Signaling Pathways—ERBB2—brain cancer	0.00014	0.000521	CbGpPWpGaD
Orlistat—DAGLB—Signaling Pathways—ERBB2—brain cancer	0.00014	0.000521	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—GLI1—brain cancer	0.000137	0.000509	CbGpPWpGaD
Orlistat—PLA2G4A—Hemostasis—PIK3CG—brain cancer	0.000134	0.000498	CbGpPWpGaD
Orlistat—PLA2G4A—Integrated Pancreatic Cancer Pathway—TP53—brain cancer	0.000132	0.000491	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—SUFU—brain cancer	0.00013	0.000483	CbGpPWpGaD
Orlistat—DAGLA—Signaling Pathways—IL2—brain cancer	0.000127	0.000472	CbGpPWpGaD
Orlistat—DAGLB—Signaling Pathways—IL2—brain cancer	0.000127	0.000472	CbGpPWpGaD
Orlistat—FASN—Metabolism—PIK3CG—brain cancer	0.000127	0.000471	CbGpPWpGaD
Orlistat—PNLIP—Disease—STAT3—brain cancer	0.000127	0.00047	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—GFAP—brain cancer	0.000126	0.000466	CbGpPWpGaD
Orlistat—DAGLB—Signaling Pathways—CCND1—brain cancer	0.000124	0.00046	CbGpPWpGaD
Orlistat—DAGLA—Signaling Pathways—CCND1—brain cancer	0.000124	0.00046	CbGpPWpGaD
Orlistat—DAGLA—Signaling Pathways—CTNNB1—brain cancer	0.000123	0.000456	CbGpPWpGaD
Orlistat—DAGLB—Signaling Pathways—CTNNB1—brain cancer	0.000123	0.000456	CbGpPWpGaD
Orlistat—PLA2G4A—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	0.000122	0.000453	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling by GPCR—VAV1—brain cancer	0.000121	0.00045	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—HEY1—brain cancer	0.000119	0.000441	CbGpPWpGaD
Orlistat—PLA2G4A—Metabolism—ENO2—brain cancer	0.000119	0.00044	CbGpPWpGaD
Orlistat—PNLIP—Disease—MYC—brain cancer	0.000118	0.000437	CbGpPWpGaD
Orlistat—FASN—Disease—ERBB2—brain cancer	0.000118	0.000436	CbGpPWpGaD
Orlistat—PNLIP—Signaling Pathways—RELA—brain cancer	0.000117	0.000435	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—DLL1—brain cancer	0.000117	0.000433	CbGpPWpGaD
Orlistat—PNLIP—Signaling Pathways—ERBB2—brain cancer	0.000116	0.000432	CbGpPWpGaD
Orlistat—PNLIP—Disease—EGFR—brain cancer	0.000115	0.000427	CbGpPWpGaD
Orlistat—DAGLB—Signaling Pathways—VEGFA—brain cancer	0.000108	0.000401	CbGpPWpGaD
Orlistat—DAGLA—Signaling Pathways—VEGFA—brain cancer	0.000108	0.000401	CbGpPWpGaD
Orlistat—DAGLB—Signaling Pathways—STAT3—brain cancer	0.000107	0.000397	CbGpPWpGaD
Orlistat—DAGLA—Signaling Pathways—STAT3—brain cancer	0.000107	0.000397	CbGpPWpGaD
Orlistat—PNLIP—Signaling Pathways—IL2—brain cancer	0.000106	0.000391	CbGpPWpGaD
Orlistat—FASN—Disease—CTNNB1—brain cancer	0.000103	0.000382	CbGpPWpGaD
Orlistat—PNLIP—Signaling Pathways—CCND1—brain cancer	0.000103	0.000382	CbGpPWpGaD
Orlistat—PNLIP—Signaling Pathways—CTNNB1—brain cancer	0.000102	0.000378	CbGpPWpGaD
Orlistat—DAGLA—Signaling Pathways—MYC—brain cancer	9.96e-05	0.000369	CbGpPWpGaD
Orlistat—DAGLB—Signaling Pathways—MYC—brain cancer	9.96e-05	0.000369	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—SHH—brain cancer	9.92e-05	0.000368	CbGpPWpGaD
Orlistat—DAGLB—Signaling Pathways—EGFR—brain cancer	9.74e-05	0.000361	CbGpPWpGaD
Orlistat—DAGLA—Signaling Pathways—EGFR—brain cancer	9.74e-05	0.000361	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—TRPC6—brain cancer	9.57e-05	0.000355	CbGpPWpGaD
Orlistat—PLA2G4A—Hemostasis—IL2—brain cancer	9.45e-05	0.000351	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—PTCH1—brain cancer	9.41e-05	0.000349	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—SMO—brain cancer	9.41e-05	0.000349	CbGpPWpGaD
Orlistat—FASN—Disease—STAT3—brain cancer	8.97e-05	0.000333	CbGpPWpGaD
Orlistat—PNLIP—Signaling Pathways—VEGFA—brain cancer	8.97e-05	0.000333	CbGpPWpGaD
Orlistat—PNLIP—Signaling Pathways—STAT3—brain cancer	8.88e-05	0.000329	CbGpPWpGaD
Orlistat—FASN—Disease—MYC—brain cancer	8.33e-05	0.000309	CbGpPWpGaD
Orlistat—PNLIP—Signaling Pathways—MYC—brain cancer	8.25e-05	0.000306	CbGpPWpGaD
Orlistat—DAGLB—Signaling Pathways—TP53—brain cancer	8.18e-05	0.000303	CbGpPWpGaD
Orlistat—DAGLA—Signaling Pathways—TP53—brain cancer	8.18e-05	0.000303	CbGpPWpGaD
Orlistat—FASN—Disease—EGFR—brain cancer	8.15e-05	0.000302	CbGpPWpGaD
Orlistat—PNLIP—Signaling Pathways—EGFR—brain cancer	8.07e-05	0.000299	CbGpPWpGaD
Orlistat—PLA2G4A—Hemostasis—VEGFA—brain cancer	8.03e-05	0.000298	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling by GPCR—PIK3CG—brain cancer	7.71e-05	0.000286	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—NOTCH2—brain cancer	7.52e-05	0.000279	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—VAV1—brain cancer	7.17e-05	0.000266	CbGpPWpGaD
Orlistat—PNLIP—Signaling Pathways—TP53—brain cancer	6.77e-05	0.000251	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—HES1—brain cancer	6.17e-05	0.000229	CbGpPWpGaD
Orlistat—PLA2G4A—Hemostasis—TP53—brain cancer	6.07e-05	0.000225	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—PDGFRA—brain cancer	5.87e-05	0.000218	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—SPP1—brain cancer	5.7e-05	0.000211	CbGpPWpGaD
Orlistat—PLA2G4A—Metabolism—PIK3CG—brain cancer	5.44e-05	0.000202	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling by GPCR—IL2—brain cancer	5.42e-05	0.000201	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—IRS2—brain cancer	5.15e-05	0.000191	CbGpPWpGaD
Orlistat—CYP3A4—Metabolism—CYP2C9—brain cancer	4.81e-05	0.000178	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—APC—brain cancer	4.55e-05	0.000169	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—PIK3CG—brain cancer	4.55e-05	0.000169	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling by GPCR—EGFR—brain cancer	4.15e-05	0.000154	CbGpPWpGaD
Orlistat—CYP3A4—Metabolism—BSG—brain cancer	4.09e-05	0.000152	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—RELA—brain cancer	3.56e-05	0.000132	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—ERBB2—brain cancer	3.53e-05	0.000131	CbGpPWpGaD
Orlistat—CYP3A4—Metabolism—IDH1—brain cancer	3.52e-05	0.00013	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—IL2—brain cancer	3.2e-05	0.000119	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—CCND1—brain cancer	3.12e-05	0.000116	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—CTNNB1—brain cancer	3.09e-05	0.000115	CbGpPWpGaD
Orlistat—CYP3A4—Metabolism—ENO2—brain cancer	2.78e-05	0.000103	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—VEGFA—brain cancer	2.72e-05	0.000101	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—STAT3—brain cancer	2.7e-05	0.0001	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—MYC—brain cancer	2.5e-05	9.29e-05	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—EGFR—brain cancer	2.45e-05	9.09e-05	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—TP53—brain cancer	2.06e-05	7.63e-05	CbGpPWpGaD
Orlistat—CYP3A4—Metabolism—PIK3CG—brain cancer	1.27e-05	4.73e-05	CbGpPWpGaD
